Asian Systemic Radiotherapy Market Research Report
- Report Code: SY 1004
- Publish Date: Upcoming
The Asian Systemic Radiotherapy Market is driven by rapidly changing cancer treatment technology and growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma. This market was valued at $114.1 million in 2013 and is expected to reach $140.1 million by 2018, at a CAGR of 4.2%.
The report “Systemic Radiotherapy Market forecast, 2012-2018” analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.These radiation sources are generally applied in combination with chemotherapy for the cancer treatment. Among these sources, I-131 is the most preferred isotope to other sources. Types of Systemic Radiotherapy market are Intravenous administration and Oral administration. Systemic Radiotherapy is generally used in combination with radiosurgery, general surgery or External beam radiotherapy for non-systemic Cancers.
In Asia (India, China, and Japan) the rising rate of cancer population has been driving the market growth. The market growth is higher in North America because it is always inclined to the usage of new technologies; whereas slow-moving markets such as Europe and Japan still make use of old technologies and are slowly evolving with the increasing usage of newer technologies.
This entire Systemic Radiotherapy devices market holds a minor share in the Asian radiotherapy market due to its new entry in this market and highly expensive treatment procedure compared to existing treatment alternatives. There are a few procedures for the treatment of blood borne and bone cancer. As these radio sources are transported through blood stream, it is often considered as the gold standard for blood and bone cancers.
The report also provides an extensive competitive landscaping of companies operating in Systemic Radiotherapy market. The main companies operating in Systemic Radiotherapy Market and extensively covered in this report are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of Systemic Radiotherapy Devices products (Segment wise)
- Product Matrix which gives a detailed comparison of Systemic Radiotherapy Devices product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the Systemic Radiotherapy Devices products (Segment wise and Country wise)
- Comprehensive coverage of Systemic Radiotherapy Devices Product approvals, Pipeline products and Product recalls.
Epidemiology Data
- Country specific Prevalence of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma
- Country specific Patient pool of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma
- Disease progression (Pattern analysis)
Procedure Volume Data
- Number of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma Surgeries performed annually in each Country tracked till sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost Analysis of Systemic Radiotherapy Devices in Various Asian Countries.
- Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma procedural investment in major countries.
Competitive Intelligence
- The company share analysis of Systemic Radiotherapy Devices for the top players of the market in the region.
- The crucial developments and strategies of companies creating their portfolios for Systemic Radiotherapy Devices.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Radiotherapy Devices Market The North American Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1878.7 million in 2013 and expected to be $2072.9 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European Radiotherapy Devices Market The European Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $915.4 million in 2013 and expected to be $1028.1 million by 2018, growing at a CAGR of 2.3%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian Radiotherapy Devices Market The Asian Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $847.8 million in 2013 and expected to be $1107.8 million by 2018, growing at a CAGR of 5.5%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
